ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "quality of life"

  • Abstract Number: 2239 • ACR Convergence 2022

    Effect of Treatment with IVIG (octagam10%) on Skin Symptoms and Quality of Life in Subjects with Dermatomyositis. Results of a Large, Randomized, Placebo-controlled International Phase III Trial

    Rohit Aggarwal1, Christina Charles-Schoeman2, joachim Schessl3, Victoria Werth4, Zsuzsanna Bata-Csorgo5, Mazen Dimachkie6, Zoltan Griger7, Sergey Moiseev8, Chester Oddis9, Elena Schiopu10, Jiří Vencovský11, Irene Beckmann12, Elisabeth Clodi13, Todd Levine14 and and the ProDERM investigators15, 1Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 2Division of Rheumatology, University of California, Los Angeles, Santa Monica, CA, 3Friedrich-Baur-Institut/Medical University Munich, Mainkofen, Germany, 4Philadelphia VAMC, Philadelphia, PA, USA and Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, 5University of Szeged, Faculty of Medicine, Szeged, Hungary, 6University of Kansas Medical Center, Kansas City, KS, 7University of Debrecen, Debrecen, Hungary, 8First Moscow State Medical University, Moscow, Russia, 9University of Pittsburgh, Pittsburgh, PA, 10Michigan Medicine Rheumatology Clinic – Taubman Center, Ann Arbor, MI, 11Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 12Octapharma PharmazeutikaProduktionsGesmbH, Vienna, Austria, 13Octapharma Pharmazeutika ProduktionsgesmbH, Vienna, Austria, 14Phoenix Neurological Associates, Ltd., Phoenix, AZ, 15Institutions in Europe and North America, Vienna, Austria

    Background/Purpose: Dermatomyositis (DM) is a rare chronic systemic autoimmune disease with characteristic skin rashes and progressive proximal muscle weakness. The efficacy of IVIg treatment in…
  • Abstract Number: 0441 • ACR Convergence 2022

    Patient-Reported Outcomes in ANCA-Associated Vasculitis: Interactions Between Patients’ and Physicians’ Perspectives in a Mexican Cohort

    José Joel Hurtado-Arias1, Isabela Ramírez-Mulhern2, Javier Merayo-Chalico3, Carlos A. Gonzalez-Martinez4, Ana Barrera-Vargas2 and Andrea Hinojosa-Azaola1, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico, 2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico, 3Instituto Nacional de Ciencias Medicas y Nutricion "Salvador Zubiran", Ciudad de México, Mexico, 4Department of Urology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico

    Background/Purpose: The antineutrophil cytoplasm antibody (ANCA) associated vasculitis (AAV) are a group of complex chronic diseases resulting in morbidity, accumulated organ damage, treatment burden, and…
  • Abstract Number: 1448 • ACR Convergence 2022

    Utility of Digital Signals and Patient Reported Data Gathered in a Decentralized Study to Predict SLE Patient-Reported Flares

    Eldon Jupe1, Gerald Lushington2, Mohan Purushothaman1, Fabricio Pautasso1, Georg Armstrong1, Arif Sorathia1, Jessica Crawley1, Vijay Nadipelli3, Bernie Rubin4, Ryan Newhardt1, Melissa Munroe1 and Brett Adelman1, 1Progentec Diagnostics, Inc., Oklahoma City, OK, 2Progentec Diagnostics, Inc., Oklahoma City, OR, 3GlaxoSmithKline, Philadelphia, PA, 4GlaxoSmithKline, US Medical Affairs and Immuno-inflammation, Durham, NC

    Background/Purpose: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease characterized by varied immune dysregulation. SLE patients often experience episodic flares, leading to organ damage…
  • Abstract Number: PP03 • ACR Convergence 2022

    To Err Is Human: The Need for Patients with Rheumatic and Musculoskeletal Diseases to Continuously Monitor Their Health Care Records

    Ida Hakkarinen, Greenbelt, MD

    Background/Purpose: In November 1999, the Institute of Medicine issued a press release announcing publication of To Err is Human: Building a Safer Health System (Kohn…
  • Abstract Number: 0444 • ACR Convergence 2022

    Prevalence of Frailty and Associated Factors in Patients with Vasculitis

    Sebastian Sattui1, John Stadler2, Cristina Burroughs3, Kalen Larson2, Christine Yeung4, Peter Merkel5 and Robert Spiera6, 1University of Pittsburgh, Pittsburgh, PA, 2Vasculitis Foundation, Kansas City, MO, 3University of South Florida, Tampa, FL, 4University of Pennsylvania, Philadelphia, 5University of Pennsylvania, Philadelphia, PA, 6Hospital for Special Surgery, New York, NY

    Background/Purpose: Frailty is a syndrome characterized by an increased vulnerability to stressors and is associated with disability and early mortality. Frailty may be accelerated in…
  • Abstract Number: 1495 • ACR Convergence 2022

    How Does Body Mass Index Affect Secukinumab Treatment Outcomes and Safety in Patients with Ankylosing Spondylitis? – Real World Data from a German Observational Study

    Uta Kiltz1, Jan Brandt-Juergens2, Peter Kästner3, Elke Riechers4, Daniel Peterlik5, Christina Budden5 and Hans-Peter Tony6, 1Rheumazentrum Ruhrgebiet, Herne, Germany, 2Rheumatologische Schwerpunktpraxis, Berlin, Germany, 3Ambulantes Rheumazentrum, Medizinisches Versorgungszentrum, Erfurt, Germany, 4Medizinische Hochschule Hannover, Hannover, Germany, 5Novartis Pharma GmbH, Nürnberg, Germany, 6Medizinische Klinik II - Rheumatologie/Immunologie, Universitätsklinikum Würzburg, Würzburg, Germany

    Background/Purpose: Obesity is a risk factor for worse overall health in people with ankylosing spondylitis (AS)1. The German non-interventional study AQUILA provides real-world data in…
  • Abstract Number: PP04 • ACR Convergence 2022

    Invisible to Invincible: The Role of Virtual Events in Autoimmune Advocacy, Education and Community Building

    Kara Wada, The Ohio State University, Columbus, OH

    Background/Purpose: After years of ignoring my dry eyes and mouth, unrelenting fatigue, and body pain, an off-the-cuff comment from my dental hygienist finally pushed me…
  • Abstract Number: 0729 • ACR Convergence 2022

    Understanding the Practice and Process of Patient Reported Outcome Measures Collection in North American Pediatric Rheumatology Clinics: A Survey of the Pediatric Rheumatology-Care and Outcomes Improvement Network

    Y. Ingrid Goh1, Esi Morgan2, Meghan Ryan3, Beth Gottlieb4 and Nancy Pan5, 1Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Services, SickKids Research Institute, Toronto, ON, Canada, 2Seattle Children's Hospital, Seattle, WA, 3University of Minnesota, Vadnais Heights, MN, 4Cohen Children's Medical Center, Lake Success, NY, 5Hospital for Special Surgery, New York, NY

    Background/Purpose: Patients/proxies (Pts) complete patient reported outcome measures (PROMs) to inform their healthcare team about their health status. PROMs completed by Pts prior to their…
  • Abstract Number: 1507 • ACR Convergence 2022

    Diagnostic Delay of More Than 6 Months Contributes to Poor Patient-Reported Outcome Measures in Psoriatic Arthritis

    Neel Tapryal1, George Gondo2, M. Elaine Husni3, Alice Gottlieb4 and Joseph Merola5, 1Cleveland Clinic, Rocky River, OH, 2National Psoriasis Foundation, Portland, OR, 3Cleveland Clinic, Cleveland, OH, 4Department of Dermatology, The Icahn School of Medicine at Mount Sinai, New York, NY, 5Harvard Medical School, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Psoriatic arthritis (PsA) is a type of inflammatory arthritis in which the time between symptom onset and a diagnosis of PsA is highly variable.…
  • Abstract Number: PP05 • ACR Convergence 2022

    From Practical Tips to Heartfelt Encouragement: How Social Media Can Improve Quality of Life with Rheumatic Disease

    Cheryl Crow1 and Zoe Rothblatt2, 1Arthritis Life, Bellevue, WA, 2Global Healthy Living Foundation, New York, NY

    Background/Purpose: Living with different autoimmune rheumatic diseases, we (Cheryl and Zoe) share similar struggles with disease management, and successes in learning new ways to use…
  • Abstract Number: 0739 • ACR Convergence 2022

    Effect of Tailored Self-Management Interventions on Health Outcomes in Individuals with Chronic Musculoskeletal Conditions

    Ellen Wang1, Isabel Rodrigues2 and Linda Li3, 1University of British Columbia, Arthritis Research Canada, Vancouver, BC, Canada, 2McMaster University, GERAS Centre for Aging Research, Hamilton, ON, Canada, 3University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Self-management, has been recognized as an essential component of successful chronic musculoskeletal (MSK) management; yet existing reviews of self-management interventions have found only modest…
  • Abstract Number: 1533 • ACR Convergence 2022

    Use of Body Mass Index in Prediction of Interstitial Lung Disease Related to Systemic Sclerosis Revealed by Decision Trees

    Alexandru Garaiman1, Carina Mihai1, Rucsandra Dobrota1, cosimo bruni2, Muriel Elhai1, Suzana Jordan1, Lea Stamm3, Anna-Maria Hoffmann-vold4, Oliver Distler1 and Mike Becker1, 1Department of Rheumatology, University Hospital Zurich, University of Zurich, Zürich, Switzerland, 2University of Florence, Florence, Italy, 3Department of Rheumatology, University Hospital Zurich, Zürich, Switzerland, 4Oslo University Hospital, Oslo, Norway

    Background/Purpose: Some gastrointestinal (GI) and nutritional factors are associated with the presence of interstitial lung disease related to systemic sclerosis (SSc-ILD). However, there are many…
  • Abstract Number: PP19 • ACR Convergence 2022

    Living with Rheumatoid Arthritis in a Rural Farming Community: How I Found a Rheumatologist and Got Targeted Treatment

    Vanessa Kerr, Mexico, MO

    Background/Purpose: I'm Vanessa and I've been married to James, a farmer, for 27 years. We have 5 children and when my fourth was born, I…
  • Abstract Number: 0088 • ACR Convergence 2022

    Challenges in the Management of Psoriatic Arthritis in Latin America: A Systematic Review

    Andre Ribeiro1, Larissa Dullius2, Andre Azeredo2, Laura Coates3, Odirlei Monticielo2, Charles Kohem2, Penelope Palominos2 and Natalia Sartori1, 1Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil, 2Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil, 3Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK, Oxford, England, United Kingdom

    Background/Purpose: In 2020, the International League of Associations for Rheumatology (ILAR) recommendations for management of psoriatic arthritis (PsA) were published. It aimed to adapt GRAPPA…
  • Abstract Number: 0793 • ACR Convergence 2022

    Autonomic Nervous System Dysfunction Common Among Patients with Long COVID: An Exploratory Evaluation

    Norman Gaylis1, Odense DeLaRosa1, Nayak Polissar2, Nirnaya Miljacic2 and Andrew Holman3, 1Arthritis & Rheumatic Disease Specialties, Aventura, FL, 2Mountain Whisper Light, Seattle, WA, 3Inmedix Inc, Seattle, WA

    Background/Purpose: Up to 70% of the 236 million people who have been diagnosed with SARS-CoV-2 develop post-COVID symptoms. (1) This has been defined by the…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 25
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology